These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11427501)

  • 21. Images in neuroscience. A mouse knockout.
    Caron MG
    Am J Psychiatry; 1996 Nov; 153(11):1387. PubMed ID: 8890669
    [No Abstract]   [Full Text] [Related]  

  • 22. Delineation of an endogenous zinc-binding site in the human dopamine transporter.
    Norregaard L; Frederiksen D; Nielsen EO; Gether U
    EMBO J; 1998 Aug; 17(15):4266-73. PubMed ID: 9687495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic drugs alter the dopamine transporter-mediated uptake and release of dopamine: a possible mechanism for drug-induced tardive dyskinesia.
    Lee SH; Oh DY; Jung SC; Kim YM; Cho HK; Koh JK; Lee YS
    Pharmacol Res; 1997 May; 35(5):447-50. PubMed ID: 9308073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Slowing Parkinson's disease progression: recent dopamine agonist trials.
    Pan T; Le W; Jankovic J
    Neurology; 2004 Jan; 62(2):343; author reply 343-4. PubMed ID: 14750218
    [No Abstract]   [Full Text] [Related]  

  • 25. VNTR polymorphism for the human dopamine transporter gene (DAT1).
    Byerley W; Hoff M; Holik J; Caron MG; Giros B
    Hum Mol Genet; 1993 Mar; 2(3):335. PubMed ID: 8098980
    [No Abstract]   [Full Text] [Related]  

  • 26. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.
    Sora I; Wichems C; Takahashi N; Li XF; Zeng Z; Revay R; Lesch KP; Murphy DL; Uhl GR
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7699-704. PubMed ID: 9636213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortex.
    Stahl SM
    J Clin Psychiatry; 2003 Mar; 64(3):230-1. PubMed ID: 12716261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.
    Giros B; el Mestikawy S; Godinot N; Zheng K; Han H; Yang-Feng T; Caron MG
    Mol Pharmacol; 1992 Sep; 42(3):383-90. PubMed ID: 1406597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Images in neuroscience. Molecular biology, II. A dopamine transporter mouse knockout.
    Caron MG
    Am J Psychiatry; 1996 Dec; 153(12):1515. PubMed ID: 8942444
    [No Abstract]   [Full Text] [Related]  

  • 30. Geometry and kinetics of dopaminergic transmission in the rat striatum and in mice lacking the dopamine transporter.
    Gonon F; Burie JB; Jaber M; Benoit-Marand M; Dumartin B; Bloch B
    Prog Brain Res; 2000; 125():291-302. PubMed ID: 11098665
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.
    Glowniak JV; Kilty JE; Amara SG; Hoffman BJ; Turner FE
    J Nucl Med; 1993 Jul; 34(7):1140-6. PubMed ID: 8315492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine induces phenotypic differentiation or apoptosis in a dose-dependent fashion: involvement of the dopamine transporter and p53.
    Porat S; Premkumar A; Simantov R
    Dev Neurosci; 2001; 23(6):432-40. PubMed ID: 11872944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine transporter mediated release of dopamine: role of chloride.
    Sitges M; Reyes A; Chiu LM
    J Neurosci Res; 1994 Sep; 39(1):11-22. PubMed ID: 7807588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a recombinant human dopamine transporter in multiple cell lines.
    Eshleman AJ; Neve RL; Janowsky A; Neve KA
    J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cloned dopamine transporter. Potential insights into Parkinson's disease pathogenesis.
    Uhl GR; Kitayama S
    Adv Neurol; 1993; 60():321-4. PubMed ID: 8380524
    [No Abstract]   [Full Text] [Related]  

  • 36. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
    Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
    J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitrogen-based drugs are not essential for blockade of monoamine transporters.
    Madras BK; Pristupa ZB; Niznik HB; Liang AY; Blundell P; Gonzalez MD; Meltzer PC
    Synapse; 1996 Dec; 24(4):340-8. PubMed ID: 10638825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Release of dopamine via the human transporter.
    Eshleman AJ; Henningsen RA; Neve KA; Janowsky A
    Mol Pharmacol; 1994 Feb; 45(2):312-6. PubMed ID: 7906856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.
    Syringas M; Janin F; Giros B; Costentin J; Bonnet JJ
    Br J Pharmacol; 2001 Jun; 133(3):387-94. PubMed ID: 11375255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human dopamine transporter gene not linked to schizophrenia in multigenerational pedigrees.
    Byerley W; Coon H; Hoff M; Holik J; Waldo M; Freedman R; Caron MG; Giros B
    Hum Hered; 1993; 43(5):319-22. PubMed ID: 8406521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.